What is the address of MAUREEN VERSTAPPEN KINESITHERAPIE?

The registered office of MAUREEN VERSTAPPEN KINESITHERAPIE is located at Is. Meyskensstraat 144, 1780 Wemmel.

Is MAUREEN VERSTAPPEN KINESITHERAPIE still active?

Yes. According to the CBE (16 September 2026) MAUREEN VERSTAPPEN KINESITHERAPIE is active, legal situation “Normale toestand”, started on 26 April 2021.

Is MAUREEN VERSTAPPEN KINESITHERAPIE registered on Peppol?

Yes, MAUREEN VERSTAPPEN KINESITHERAPIE is registered on the Peppol network with ID 0208:0767514775.

What is the enterprise number of MAUREEN VERSTAPPEN KINESITHERAPIE?

The enterprise number of MAUREEN VERSTAPPEN KINESITHERAPIE is BE0767514775.

When was MAUREEN VERSTAPPEN KINESITHERAPIE founded?

MAUREEN VERSTAPPEN KINESITHERAPIE was founded on 26 April 2021.

Who are the directors of MAUREEN VERSTAPPEN KINESITHERAPIE?

According to the 2025 annual accounts, the directors of MAUREEN VERSTAPPEN KINESITHERAPIE are: MAUREEN VERSTAPPEN.

Is MAUREEN VERSTAPPEN KINESITHERAPIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 April 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MAUREEN VERSTAPPEN KINESITHERAPIE make in 2025?

MAUREEN VERSTAPPEN KINESITHERAPIE posted a profit after taxes of € 8,970 in financial year 2025.

What is the revenue of MAUREEN VERSTAPPEN KINESITHERAPIE?

As a small company, MAUREEN VERSTAPPEN KINESITHERAPIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 14,492.

MAUREEN VERSTAPPEN KINESITHERAPIE (Private Limited)

Dossier MAUREEN VERSTAPPEN KINESITHERAPIE, printed on 16 September 2026 from databakkes.be/en/0767514775/maureen-verstappen-kinesitherapie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MAUREEN VERSTAPPEN KINESITHERAPIE from Wemmel, company number BE0767514775, closed financial year 2025 with a result of € 8,970 after tax. For that financial year MAUREEN VERSTAPPEN KINESITHERAPIE recorded a gross margin of € 14,492 and equity of € 48,440. Compared with financial year 2024, the result moved from € 11,713 to € 8,970. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.

What it is worth Growing

€ 48,440

▲ 23% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 8,970

▼ 23% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 40,407

▲ 3% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 47,040.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 197

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,814

▼ 59% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 26,526 Gross margin 2022: € 26,526 First fiscal year in the series	€ 18,333 Gross margin 2023: € 18,333 ▼ 31% vs 2022 (€ 26,526) Unfavourable step	€ 20,292 Gross margin 2024: € 20,292 ▲ 11% vs 2023 (€ 18,333) Favourable step	€ 14,492 Gross margin 2025: € 14,492 ▼ 29% vs 2024 (€ 20,292) Unfavourable step	▼ 29%
Profit after taxes	€ 16,685 Profit after taxes 2022: € 16,685 First fiscal year in the series	€ 11,756 Profit after taxes 2023: € 11,756 ▼ 30% vs 2022 (€ 16,685) Unfavourable step	€ 11,713 Profit after taxes 2024: € 11,713 Unchanged (€ 11,756) Unfavourable step	€ 8,970 Profit after taxes 2025: € 8,970 ▼ 23% vs 2024 (€ 11,713) Unfavourable step	▼ 23%
Equity	€ 37,000 Equity 2022: € 37,000 First fiscal year in the series	€ 37,256 Equity 2023: € 37,256 ▲ 1% vs 2022 (€ 37,000) Favourable step	€ 39,470 Equity 2024: € 39,470 ▲ 6% vs 2023 (€ 37,256) Favourable step	€ 48,440 Equity 2025: € 48,440 ▲ 23% vs 2024 (€ 39,470) Favourable step	▲ 23%
Total debts	€ 12,508 Total debts 2022: € 12,508 First fiscal year in the series	€ 16,346 Total debts 2023: € 16,346 ▲ 31% vs 2022 (€ 12,508) Unfavourable step	€ 21,168 Total debts 2024: € 21,168 ▲ 30% vs 2023 (€ 16,346) Unfavourable step	€ 5,011 Total debts 2025: € 5,011 ▼ 76% vs 2024 (€ 21,168) Favourable step	▼ 76%
Cash	€ 40,685 Cash 2022: € 40,685 First fiscal year in the series	€ 27,733 Cash 2023: € 27,733 ▼ 32% vs 2022 (€ 40,685) Unfavourable step	€ 39,043 Cash 2024: € 39,043 ▲ 41% vs 2023 (€ 27,733) Favourable step	€ 40,407 Cash 2025: € 40,407 ▲ 3% vs 2024 (€ 39,043) Favourable step	▲ 3%
Retained profit	€ 35,600 Retained profit 2022: € 35,600 First fiscal year in the series	€ 35,856 Retained profit 2023: € 35,856 ▲ 1% vs 2022 (€ 35,600) Favourable step	€ 38,070 Retained profit 2024: € 38,070 ▲ 6% vs 2023 (€ 35,856) Favourable step	€ 47,040 Retained profit 2025: € 47,040 ▲ 24% vs 2024 (€ 38,070) Favourable step	▲ 24%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 11,500 Dividend 2023: € 11,500 Unchanged (€ 0) Unchanged	€ 9,500 Dividend 2024: € 9,500 ▼ 17% vs 2023 (€ 11,500) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 9,500) Unchanged	▼ 100%
Balance sheet total	€ 49,509 Balance sheet total 2022: € 49,509 First fiscal year in the series	€ 53,602 Balance sheet total 2023: € 53,602 ▲ 8% vs 2022 (€ 49,509) Unchanged	€ 60,637 Balance sheet total 2024: € 60,637 ▲ 13% vs 2023 (€ 53,602) Unchanged	€ 53,450 Balance sheet total 2025: € 53,450 ▼ 12% vs 2024 (€ 60,637) Unchanged	▼ 12%

Key figures of MAUREEN VERSTAPPEN KINESITHERAPIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MAUREEN VERSTAPPEN KINESITHERAPIE?

What happened at MAUREEN VERSTAPPEN KINESITHERAPIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 16, 2026 New annual accounts for financial year 2025: profit of € 8,970 (▼ 23% vs 2024). Source: NBB ↗
Apr 26, 2021 New establishment in Wemmel. KBO
Apr 26, 2021 Start of the company according to the CBE. KBO

In short

From € 16,685 profit in 2022 to € 8,970 profit in 2025.

Paid € 22,735 in corporate taxes since 2022.

Best year ever: 2022, with € 16,685 profit.

Paid out € 21,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at MAUREEN VERSTAPPEN KINESITHERAPIE? We notify you, reason included.

Follow MAUREEN VERSTAPPEN KINESITHERAPIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

MAUREEN VERSTAPPEN

MAUREEN VERSTAPPEN KINESITHERAPIE

Behind MAUREEN VERSTAPPEN KINESITHERAPIE is MAUREEN VERSTAPPEN.

See the full network in the app

Directors

According to the 2025 annual accounts

MAUREEN VERSTAPPEN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Is. Meyskensstraat 144

1780 Wemmel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0767.514.775
VAT number: BE 0767.514.775
Registered office: Is. Meyskensstraat 144, 1780 Wemmel
Names & denominations: MAUREEN VERSTAPPEN KINESITHERAPIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 April 2021
Peppol: Active · Active since 19 Apr 2026

View on CBE Public ↗ Annual accounts (NBB) ↗